Abstract:OBJECTIVE: We investigated the relationship between plasma miRNAs levels and inflammatory characteristics in asthmatic patients.METHODS: Eligible adults with untreated asthma (n = 35) underwent a clinical assessment, sputum induction, and assessment of pulmonary function test and Asthma Control Test (ACT) scores. Asthma phenotypes were defined using the sputum cell count. miR-199a-5p expression was measured using quantitative real-time polymerase chain reaction (qPCR). Lipopolysaccharide (LPS) stimulation was used to detect miR-199a-5p secretion from peripheral blood-derived neutrophil, lymphocyte, macrophage and BEAS-2B cells. The correlation of miR-199a-5p expression with clinical parameters was analyzed using multiple linear regression analysis. In silico analysis predicted the target genes and signaling pathway of miR-199a-5p. Transfection of miR-199a-5p mimics in human airway smooth muscle cells (HASMCs) was performed in vitro.RESULTS: The miRNA-199a-5p levels in plasma and sputum increased significantly in patients with neutrophilic asthma compared to healthy subjects (ps = 0.014 and 0.006, respectively). Expression of miR-199a-5p in the plasma of asthmatic patients positively correlated with sputum miR-199a-5p expression (r = 0.511, p = 0.021). The miR-199a-5p level was only elevated with LPS stimulation in neutrophils but not macrophages, lymphocytes, or epithelial cells from healthy controls (p < 0.01). miR-199a-5p expression increased in response to LPS (p = 0.005) and LPS combined with IL-4 (p = 0.003), but not IL-4 alone. However, peripheral neutrophils from eosinophilic asthma patients did not respond to LPS with increased miR-199a-5p expression (n = 5, p > 0.05) in contrast to the significant response from neutrophilic patients (n = 4, p < 0.0001). miR-199a-5p negatively correlated with FEV1, FVC and PEF (r = -0.377, p = 0.026; r = -0.419, p = 0.012; and r = -0.392, p = 0.024, respectively). Multivariate correlation analysis confirmed that the plasma miR-199a-5p levels negatively correlated with FEV1 in patients with asthma (Adjusted R2 = 0.164, p = 0.015). In silico analysis suggested that the WNT signaling pathway participates in miR-199a-5p mediation of smooth muscle cell hypertrophy. In vitro experiment, miR-199a-5p mimics inhibited the protein expressions of WNT2 and WNT4, decreased the c-myc expression and dramatically increased the Sm-MHC expression in HASMCs.CONCLUSION: Plasma miR-199a-5p was increased in neutrophilic asthma and negatively correlated with pulmonary function, which suggests that miR-199a-5p actively contributes to disease pathogenesis by modulating the inflammatory process and transferring the signal from inflammatory cells to structure cells.

Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors

MicroRNA in Children with Asthma: Findings from Bronchoalveolar Lavage Fluid

Identification of a Plasma Mirna Biomarker Signature for Allergic Asthma: A Translational Approach

The Differential Expression Profiles of Mirna-Let 7a, 7b, and 7c in Bronchoalveolar Lavage Fluid from Infants with Asthma and Airway Foreign Bodies

Pulmonary Microrna Profiles Identify Involvement of Creb1 and Sec14l3 in Bronchial Epithelial Changes in Allergic Asthma

MicroRNA-155 differentially regulates IL-13Rα1 and IL-13Rα2 expression and signaling that drives abnormal epithelial cells functions in severe asthma

Specific microRNA Profile Associated with Inflammation and Lipid Metabolism for Stratifying Allergic Asthma Severity

Asthma diagnosis using integrated analysis of eosinophil microRNAs

Serum exosome inflamma‐miRs are surrogate biomarkers for asthma phenotype and severity

miRNA-based identification of SEC14L3 deregulation in murine experimental asthma

A comprehensive analysis of microRNAs as diagnostic biomarkers for asthma

MiR-185-5p Measurement Assists in Reflecting Th1/Th2 Cell Imbalance, Inflammatory Cytokine Production, and Exacerbation Risk for Childhood Asthma.

Plasma miR-199a-5p is increased in neutrophilic phenotype asthma patients and negatively correlated with pulmonary function

Circulating miRNAs act as potential biomarkers for asthma

Biomarkers associated with disease severity in allergic and nonallergic asthma

Dysregulation of MicroRNAs in Peripheral Blood Mononuclear Cells from Severe Asthmatic Patients

Increases in peripheral SIRT1: A new biological characteristic of asthma.

Tuning into miRNAs: A Comprehensive Analysis of their Impact on Diagnosis, and Progression in Asthma

MicroRNA Profiling of the Inflammatory Response after Early and Late Asthmatic Reaction

Identification and validation of three potential biomarkers and immune microenvironment for in severe asthma in microarray and single-cell datasets

Integrative Analysis Reveals a Mirna-Mrna Regulatory Network and Potential Causative Agents in the Asthmatic Airway Epithelium